GEOFF MULVIHILL Associated Press

Newest opioid negotiation strategy with OxyContin manufacturer Purdue and Sackler

Newest opioid negotiation strategy with OxyContin manufacturer Purdue and Sackler

GEOFF MULVIHILL Associated Press November 14, 2025

NEW YORK CITY– Attorneys standing for OxyContin manufacturer Purdue Pharma, branches of the Sackler family members that...

Purdue Pharma’s $7B opioid negotiation strategy can obtain ballots from targets and cities

Purdue Pharma’s $7B opioid negotiation strategy can obtain ballots from targets and cities

GEOFF MULVIHILL Associated Press June 20, 2025

OxyContin manufacturer Purdue Pharma‘s $7 billion-plus strategy to resolve hundreds of suits over the toll of opioids...

A court might progress Purdue Pharma’s $7B opioid negotiation besides 50 states back it

A court might progress Purdue Pharma’s $7B opioid negotiation besides 50 states back it

GEOFF MULVIHILL Associated Press June 18, 2025

All 50 united state states have actually consented to the OxyContin manufacturer Purdue Pharma‘s most recent strategy...